Clevudine is a nucleoside analogue antiviral agent classified as a cytidine derivative, primarily utilized for the treatment of chronic hepatitis B infection by inhibiting viral DNA polymerase to terminate… Read more
Clevudine is a nucleoside analogue antiviral agent classified as a cytidine derivative, primarily utilized for the treatment of chronic hepatitis B infection by inhibiting viral DNA polymerase to terminate viral chain elongation. This category features high-quality reference standards of Clevudine API, along with associated compounds such as 2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil, which serve as essential tools in pharmaceutical research and quality control. Laboratories use these materials for rigorous impurity profiling, accurate metabolite identification, and the validation of analytical methods during drug development and stability testing. Additionally, the inclusion of stable isotope labelled compounds facilitates precise quantitative analysis in complex biological matrices. These reference standards enable consistent analytical performance and regulatory compliance for researchers characterizing the chemical profile and therapeutic efficacy of this antiviral treatment.